An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.

Ask AI
Amendment Number
712
Description
An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.
Purpose
An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.
Congress
116
Type
HAMDT
Latest Action Date
Dec 12, 2019
Latest Action Text
On agreeing to the Tonko amendment (A002) Agreed to by voice vote.
Latest Action Time
11:14:51
Submitted Date
Dec 12, 2019
Chamber
House of Representatives
Update Date
Feb 8, 2022
Amendment 712 — Informed